Generalized Myasthenia Gravis Classification and Treatment Strategy

Key Takeaways

• gMG classification considers clinical presentation, antibody status, and disease severity to guide treatment strategies.
• The MGFA clinical classification system categorizes patients from Class I (ocular symptoms) to Class V (intubation required).
• Antibody status, such as anti-acetylcholine receptor or anti-MuSK, influences treatment decisions in gMG.
• Treatment strategies aim to improve quality of life while minimizing side effects, considering disease severity and patient-specific factors.